A randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomes.

A randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomes.

<h4>Background</h4>Behavioral interventions that promote adherence to antiretroviral medications may decrease HIV treatment failure. Antiretroviral treatment programs in sub-Saharan Africa confront increasing financial constraints to provide comprehensive HIV care, which include adherenc...

Full description

Bibliographic Details
Main Authors:	Michael H Chung, Barbra A Richardson, Kenneth Tapia, Sarah Benki-Nugent, James N Kiarie, Jane M Simoni, Julie Overbaugh, Mena Attwa, Grace C John-Stewart
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2011-03-01
Series:	PLoS Medicine
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21390262/?tool=EBI

Similar Items

Incidence and correlates of HIV-1 RNA detection in the breast milk of women receiving HAART for the prevention of HIV-1 transmission.
by: Jennifer A Slyker, et al.
Published: (2012-01-01)

Male perspectives on incorporating men into antenatal HIV counseling and testing.
by: David A Katz, et al.
Published: (2009-11-01)

An adherence trilogy is essential for long-term HAART success
by: Garcia Rosa, et al.
Published: (2003-01-01)

An adherence trilogy is essential for long-term HAART success
by: Rosa Garcia, et al.

Immuno-virological response and clinical outcome in naive elderly patients treated with antiretroviral therapy (HAART)
by: Palermo F, et al.
Published: (2010-05-01)

Durable Suppression of HIV-1 after Virologic Monitoring-Based Antiretroviral Adherence Counseling in Rakai, Uganda.
by: Alexander Billioux, et al.
Published: (2015-01-01)

Impaired CCR7 Expression on Plasmacytoid Dendritic Cells in HIV Infected Children on HAART With Virologic Failure
by: Pahwa Rajendra, et al.
Published: (2005-12-01)

Rates and determinants of virologic and immunological response to HAART resumption after treatment interruption in HIV-1 clinical practice.
by: Touloumi, G, et al.
Published: (2008)

Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia.
by: Genet Gebrehiwet Hailu, et al.
Published: (2018-01-01)

Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort
by: Mbori-Ngacha Dorothy A, et al.
Published: (2010-05-01)

Electronic medication monitoring-informed counselling to improve adherence to combination antiretroviral therapy and virologic treatment outcomes: a meta-analysis
by: Nienke eLangebeek, et al.
Published: (2015-05-01)

Factors associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland.
by: Kiran Jobanputra, et al.
Published: (2015-01-01)

Adherence to HAART: Africans take medicines more faithfully than North Americans.
by: Amir Attaran
Published: (2007-02-01)

Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: a retrospective case control study
by: Ganesan Anuradha, et al.
Published: (2011-05-01)

Corrigendum: Electronic medication monitoring-informed counselling to improve adherence to combination antiretroviral therapy and virologic treatment outcomes: a meta-analysis
by: Pythia eNieuwkerk
Published: (2016-05-01)

Pharmacology and immuno-virologic efficacy of once-a-day HAART in African HIV-infected children: ANRS 12103 phase II trial
by: Boubacar Nacro, et al.
Published: (2011-06-01)

Lopinavir/ritonavir as part of schemes of HAARt in HIV-positive pregnant women and women of reproductive age: the dynamics of clinical and immunological and virological indicators
by: A. B. Konkova-Reidman, et al.
Published: (2015-04-01)

Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment
by: Snidow Jerry W, et al.
Published: (2005-01-01)

Predictors of Virological Failure after Adherence-Enhancement Counseling among First-Line Adults Living with HIV/AIDS in Kombolcha Town, Northeast Ethiopia
by: Bisetegn G, et al.
Published: (2021-01-01)

Antibody-dependent cellular cytotoxicity targeting CD4-inducible epitopes predicts mortality in HIV-infected infantsResearch in context
by: Nicole E. Naiman, et al.
Published: (2019-09-01)

How well does self-reported adherence fare compared to therapeutic drug monitoring in HAART?
by: Bulgiba, A., et al.
Published: (2013)

Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators.
by: Edward J Mills, et al.
Published: (2006-11-01)

Self-reported adherence to HAART in South-Eastern Nigeria is related to patients' use of pill box
by: Chinwe V Ukwe, et al.
Published: (2010-07-01)

Determinants of virological failure among patients on first line highly active antiretroviral therapy (HAART) in Southwest Ethiopia: A case-control study
by: Biruk Bogale, et al.
Published: (2022-10-01)

Neurodegeneration in the HAART era
by: Brew Bruce J
Published: (2010-05-01)

Medication Adherence and Contraceptive Counseling
by: María Inmaculada de Molina-Fernandez, et al.
Published: (2023-05-01)

Determinants of Virological Failure in HIV Patients on Highly Active Antiretroviral Therapy (HAART): A Retrospective Cross-Sectional Study in the Upper East Region of Ghana
by: Abdulai Abubakari, et al.
Published: (2023-01-01)

Interventions to promote adherence to Antiretroviral Therapy (HAART) among adult patients at an HIV/AIDS program in Uganda
by: Kutamba Elizabeth, et al.
Published: (2010-05-01)

Principles of virology /
by: Flint, S. Jane 548781, et al.
Published: (2009)

Using viral sequence diversity to estimate time of HIV infection in infants.
by: Magdalena L Russell, et al.
Published: (2023-12-01)

HAART and the liver: friend or foe?
by: Pineda JA, et al.
Published: (2010-03-01)

Chemoprophylaxis and HAART Therapy in Botswana
by: Essex M
Published: (2005-12-01)

Home visiting to an HIV positive patient prior to initiation of HAART has Lasting impact on their adherence. TASO Experience
by: Nyatia Ricky, et al.
Published: (2010-05-01)

Factors influencing HAART adherence among private health care sector patients in a suburb of the Ethekwini Metro
by: Panjasaram Naidoo
Published: (2009-05-01)

Effects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2.
by: Alison C Roxby, et al.
Published: (2012-01-01)

Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007.
by: Marie Ballif, et al.
Published: (2009-01-01)

Infant safety during and after maternal valacyclovir therapy in conjunction with antiretroviral HIV-1 prophylaxis in a randomized clinical trial.
by: Alison L Drake, et al.
Published: (2012-01-01)

BMT306 – Virology [Virologi]
by: PPSKJ, Pusat Pengajian Sains Kajihayat
Published: (2023)

Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda
by: Kalyango Joan N, et al.
Published: (2008-11-01)

Assessment of the impact of adherence and other predictors during HAART on various CD4 cell responses in resource-limited settings
by: Abrogoua DP, et al.
Published: (2012-03-01)